Yahoo Finance Sutro Biopharma, Inc. (NASDAQ:STRO) insider upped their holding by 4.3% earlier this year
Looking at Sutro Biopharma, Inc.'s (NASDAQ:STRO ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold.
While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether.
View our latest analysis for Sutro Biopharma
Sutro Biopharma Insider Transactions Over The Last Year
In the last twelve months, the biggest single purchase by an insider was when CEO & Director William Newell bought US$78k worth of shares at a price of US$7.75 per share. That means that even when the share price was higher than US$5.79 (the recent price), an insider wanted to purchase shares. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. We always take careful note of the price insiders pay when purchasing shares. As a general rule, we feel more positive about a stock when an insider has bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price. William Newell was the only individual insider to buy shares in the last twelve months.
You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.
Insider Ownership Of Sutro Biopharma
I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Our data suggests Sutro Biopharma insiders own 1.1% of the company, worth about US$3.7m. We prefer to see high levels of insider ownership.
So What Does This Data Suggest About Sutro Biopharma Insiders?
The fact that there have been no Sutro Biopharma insider transactions recently certainly doesn't bother us. However, our analysis of transactions over the last year is heartening. While we have no worries about the insider transactions, we'd be more comfortable if they owned more Sutro Biopharma stock. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Sutro Biopharma. To assist with this, we've discovered 2 warning signs that you should run your eye over to get a better picture of Sutro Biopharma.
But note: Sutro Biopharma may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here
